The Peptide Encyclopedia
Independent, sourced profiles of 30+ peptides. Each entry flags regulatory status honestly β approved medicine, research chemical, or somewhere in between β and links to primary research.
14 peptides
Afamelanotide (also known as Scenesse) is a peptide catalogued under Cognitive & Nootropic (MC1R agonist). It is described as: MC1R agonist. Documented context: Erythropoietic protoporphyria. Neutral reference entry; EU status: EU-approved prescription medicine.
A porcine-brain-derived peptide preparation marketed in some countries and studied in stroke and dementia trials; not FDA-approved.
Cerebrolysin components is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: EU-approved prescription medicine.
Delta sleep-inducing peptide is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: not approved for human use (research use only).
An angiotensin-IV-derived peptide studied in preclinical models for synaptogenesis and cognition; no human approval.
N-Acetyl Semax is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: not approved for human use (research use only).
N-Acetyl Semax Amidate (also known as NA-Semax-amidate) is a peptide catalogued under Cognitive & Nootropic (Semax derivative). Neutral reference entry; EU status: not approved for human use (research use only).
Neurotensin (also known as NT) is a peptide catalogued under Cognitive & Nootropic (Endogeen). Neutral reference entry; EU status: not approved for human use (research use only).
Noopept is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: available as an EU supplement.
A ciliary-neurotrophic-factor-derived peptidomimetic studied in preclinical neurodegeneration models; not approved for human use.
A synthetic analog of the endogenous peptide tuftsin, studied in Russia for anxiolytic and nootropic effects.
A synthetic peptide derived from adrenocorticotropic hormone fragment (4-10), studied in Russia for neuroprotective and cognitive effects.
Setmelanotide (also known as Imcivree) is a peptide catalogued under Cognitive & Nootropic (MC4R agonist). It is described as: MC4R agonist. Documented context: Genetic obesity (POMC/LEPR/PCSK1/BBS). Neutral reference entry; EU status: EU-approved prescription medicine.
Substance P (also known as SP) is a peptide catalogued under Cognitive & Nootropic (Tachykinin). It is described as: NK1 receptor. Neutral reference entry; EU status: not approved for human use (research use only).